The introduction of second-generation antipsychotic drugs for the treatment of schizophrenia
has provided significant benefits for clients experiencing this disorder. While they have
been found effective in reducing psychotic symptoms, there is evidence that these drugs are
also linked with a group of side effects commonly known as the metabolic syndrome. Mental
health nurses are well positioned to prevent, detect and/or manage the development of
this problematic constellation of symptoms. Guidelines for practice can be useful in prevention
and management of the syndrome and enhance nursing care of clients who are taking
second-generation antipsychotics.